Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-17-010371
Filing Date
2017-09-08
Accepted
2017-09-08 16:34:47
Documents
1
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form-4a.html 4/A  
1 form-4a.xml 4/A 9918
  Complete submission text file 0001493152-17-010371.txt   11378
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4908 SOUTH ASHTON COURT SPOKANE WA 99223
Business Address
CZIRR JAMES C (Reporting) CIK: 0001260641 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31791 | Film No.: 171076961